当前位置: 首页 > 期刊 > 《中国当代医药》 > 2016年第5期
编号:12770296
双歧杆菌三联活菌散联合美沙拉嗪肠溶片治疗溃疡性结肠炎的临床效果(1)
http://www.100md.com 2016年2月15日 中国当代医药 2016年第5期
     [摘要] 目的 观察双歧杆菌三联活菌散联合美沙拉嗪肠溶片治疗溃疡性结肠炎患者的临床疗效。 方法 将2014年6月~2015年6月收治的80例溃疡性结肠炎患者,根据随机数字表法分为两组,各40例,对照组应用美沙拉嗪肠溶片,观察组采用双歧杆菌三联活菌散联合美沙拉嗪肠溶片治疗,比较两组患者治疗后的治疗效果。 结果 观察组患者的治疗总有效率为90.0%,明显高于对照组的75.0%,差异有统计学意义(P<0.05);治疗后观察组患者的超氧化物歧化酶(SOD)、丙二醛(MDA)、IL-6、IL-8、IL-10、肿瘤坏死因子-α(TNF-α)以及超敏C反应蛋白(hs-CRP)表达水平较治疗前与对照组均有显著改善,差异有统计学意义(P<0.05)。结论 双歧杆菌三联活菌散联合美沙拉嗪肠溶片治疗溃疡性结肠炎患者疗效确切,可改善机体细胞因子表达。

    [关键词] 溃疡性结肠炎;双歧杆菌三联活菌散;美沙拉嗪肠溶片;细胞因子;超氧化物歧化酶

    [中图分类号] R516.1 [文献标识码] A [文章编号] 1674-4721(2016)02(b)-0143-04

    Clinical effect of Bifidobacterium triple viable powder combined with mesalazine enteric coated tablets in the treatment of patients with ulceratire colitis

    GAO Lei1 XUE Juan2

    1.Department of Digestive,the First Affiliated Hospital of Henan University of Science and Technology,Luoyang 471000,China;2.Department of Laboratory,the First Affiliated Hospital of Henan University of Science and Technology,Luoyang 471000,China

    [Abstract] Objective To observe the effect of Bifidobacterium triple live bacteria powder scattered us joint mesalazine enteric coated tablets in the treatment of the clinical efficacy of patients with ulcerative colitis. Methods 80 cases of patients with ulcerative colitis from June 2014 to June 2015 were divided into two groups based on the random number table,40 cases in each group.The control group were treated with mesalazin enteric-coated tablets,observation group were treated with Bifidobacterium triple viable powder combined with mesalazin enteric-coated tablets treatment.The treatment effects and adverse reactions of the two groups were observed. Results The treatment total effective rate of observation group was 90.0%,significantly higher than that of control group 75.0%,there was statistical significance(P<0.05).After treatment,superoxide dismutase (SOD),malondialdehyde (MDA),IL-6,IL-8,IL-10,tumor necrosis factor-α(TNF-α) and ultra sensitivity C-reactive protein (hs-CRP) expression level in the observation group were significantly improved compared with the control group,there was statistical significance(P<0.05). Conclusion Bifidobacterium triple live bacteria powder scattered us joint mesalazine enteric coated tablets are effective in the treatment of ulcerative colitis patients can improve cytokines expression.

    [Key words] Ulcerative colitis;Bifidobacterium triple live bacteria powder;Mesalazine enteric coated tablets;Cell factor;Superoxide dismutase

    溃疡性结肠炎属于非特异性炎症性疾病的一种,患者以腹痛腹泻反复发作、黏液脓血便、乏力、里急后重以及食欲不振为主要表现。本病以20~40岁人群为好发群体,对患者生活质量造成严重影响[1]。本文就此探讨双歧杆菌三联活菌散联合美沙拉嗪肠溶片治疗溃疡性结肠炎患者的临床疗效,旨在为临床提供一定指导和帮助,现报道如下。, http://www.100md.com(高磊 薛娟)
1 2 3下一页